Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1999 May 4;160(9):S7–S12.

Lifestyle modifications to prevent and control hypertension. 2. Recommendations on obesity and weight loss. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada

LA Leiter 1, D Abbott 1, NR Campbell 1, R Mendelson 1, RI Ogilvie 1, A Chockalingam 1
PMCID: PMC1230334  PMID: 10333848

Abstract

OBJECTIVE: To provide updated, evidence-based recommendations concerning the effects of weight loss and maintenance of healthy weight on the prevention and control of hypertension in otherwise healthy adults (except pregnant women). OPTIONS: The main options are to attain and maintain a healthy body weight (body mass index [BMI] 20-25 kg/m2) or not to do so. For those at risk for hypertension, weight loss and maintenance of healthy weight may prevent the condition. For those who have hypertension, weight loss and maintenance of healthy weight may reduce or obviate the need for antihypertensive medications. OUTCOMES: The health outcome considered was change in blood pressure. Because of insufficient evidence, no economic outcomes were considered. EVIDENCE: A MEDLINE search was conducted for the years 1992-1996 with the terms hypertension and obesity in combination and antihypertensive therapy and obesity in combination. Other relevant evidence was obtained from the reference lists of the articles identified, from the personal files of the authors and through contacts with experts. The articles were reviewed, classified according to study design and graded according to level of evidence. VALUES: A high value was placed on the avoidance of cardiovascular morbidity and premature death caused by untreated hypertension. BENEFITS, HARMS AND COSTS: Weight loss and the maintenance of healthy body weight reduces the blood pressure of both hypertensive and normotensive people. The indirect benefits of a health body weight are well known. The negative effects of weight loss are primarily the frustrations associated with attaining and maintaining a healthy weight. The costs associated with weight loss programs were not measured in the studies reviewed. RECOMMENDATIONS: (1) It is recommended that health care professionals determine weight (in kilograms), height (in metres) and BMI for all adults. (2) To reduce blood pressure in the population at large, it is recommended that Canadians attain and maintain a healthy BMI (20-25). (3) All overweight hypertensive patients (BMI greater than 25) should be advised to reduce their weight. VALIDATION: These recommendations are similar to those of the World Hypertension League, the National High Blood Pressure Education Program Working Group on Primary Prevention of Hypertension, the Canadian Hypertension Society and the Canadian Coalition for High Blood Pressure Prevention and Control. They have not been clinically tested. SPONSORS: The Canadian Hypertension Society, the Canadian Coalition for High Blood Pressure Prevention and Control, the Laboratory Centre for Disease Control at Health Canada, and the Heart and Stroke Foundation of Canada.

Full Text

The Full Text of this article is available as a PDF (192.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Campbell N. R., Burgess E., Choi B. C., Taylor G., Wilson E., Cléroux J., Fodor J. G., Leiter L. A., Spence D. Lifestyle modifications to prevent and control hypertension. 1. Methods and an overview of the Canadian recommendations. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada. CMAJ. 1999 May 4;160(9 Suppl):S1–S6. [PMC free article] [PubMed] [Google Scholar]
  2. Carruthers S. G., Larochelle P., Haynes R. B., Petrasovits A., Schiffrin E. L. Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. CMAJ. 1993 Aug 1;149(3):289–293. [PMC free article] [PubMed] [Google Scholar]
  3. Chockalingam A., Abbott D., Bass M., Battista R., Cameron R., de Champlain J., Evans C. E., Laidlaw J., Lee B. L., Leiter L. Recommendations of the Canadian Consensus Conference on Non-Pharmacological Approaches to the Management of High Blood Pressure, Mar. 21-23, 1989, Halifax, Nova Scotia. CMAJ. 1990 Jun 15;142(12):1397–1409. [PMC free article] [PubMed] [Google Scholar]
  4. Connolly H. M., Crary J. L., McGoon M. D., Hensrud D. D., Edwards B. S., Edwards W. D., Schaff H. V. Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 1997 Aug 28;337(9):581–588. doi: 10.1056/NEJM199708283370901. [DOI] [PubMed] [Google Scholar]
  5. Elmer P. J., Grimm R., Jr, Laing B., Grandits G., Svendsen K., Van Heel N., Betz E., Raines J., Link M., Stamler J. Lifestyle intervention: results of the Treatment of Mild Hypertension Study (TOMHS). Prev Med. 1995 Jul;24(4):378–388. doi: 10.1006/pmed.1995.1062. [DOI] [PubMed] [Google Scholar]
  6. Fagerberg B., Berglund A., Andersson O. K., Berglund G. Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids. J Hypertens. 1992 Sep;10(9):1053–1061. [PubMed] [Google Scholar]
  7. Hall J. E. Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension. 1994 Mar;23(3):381–394. doi: 10.1161/01.hyp.23.3.381. [DOI] [PubMed] [Google Scholar]
  8. Haynes R. B., Harper A. C., Costley S. R., Johnston M., Logan A. G., Flanagan P. T., Sackett D. L. Failure of weight reduction to reduce mildly elevated blood pressure: a randomized trial. J Hypertens. 1984 Oct;2(5):535–539. doi: 10.1097/00004872-198410000-00014. [DOI] [PubMed] [Google Scholar]
  9. Higgins M., Kannel W., Garrison R., Pinsky J., Stokes J., 3rd Hazards of obesity--the Framingham experience. Acta Med Scand Suppl. 1988;723:23–36. doi: 10.1111/j.0954-6820.1987.tb05925.x. [DOI] [PubMed] [Google Scholar]
  10. Huang Z., Willett W. C., Manson J. E., Rosner B., Stampfer M. J., Speizer F. E., Colditz G. A. Body weight, weight change, and risk for hypertension in women. Ann Intern Med. 1998 Jan 15;128(2):81–88. doi: 10.7326/0003-4819-128-2-199801150-00001. [DOI] [PubMed] [Google Scholar]
  11. Kolanowski J., Younis L. T., Vanbutsele R., Detry J. M. Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients. Eur J Clin Pharmacol. 1992;42(6):599–605. doi: 10.1007/BF00265922. [DOI] [PubMed] [Google Scholar]
  12. MacMahon S. W., Macdonald G. J., Bernstein L., Andrews G., Blacket R. B. Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients. Lancet. 1985 Jun 1;1(8440):1233–1236. doi: 10.1016/s0140-6736(85)92310-4. [DOI] [PubMed] [Google Scholar]
  13. Manson J. E., Willett W. C., Stampfer M. J., Colditz G. A., Hunter D. J., Hankinson S. E., Hennekens C. H., Speizer F. E. Body weight and mortality among women. N Engl J Med. 1995 Sep 14;333(11):677–685. doi: 10.1056/NEJM199509143331101. [DOI] [PubMed] [Google Scholar]
  14. Oberman A., Wassertheil-Smoller S., Langford H. G., Blaufox M. D., Davis B. R., Blaszkowski T., Zimbaldi N., Hawkins C. M. Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status. Ann Intern Med. 1990 Jan 15;112(2):89–95. doi: 10.7326/0003-4819-112-2-89. [DOI] [PubMed] [Google Scholar]
  15. Ramsay L. E., Ramsay M. H., Hettiarachchi J., Davies D. L., Winchester J. Weight reduction in a blood pressure clinic. Br Med J. 1978 Jul 22;2(6132):244–245. doi: 10.1136/bmj.2.6132.244. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Reeder B. A., Angel A., Ledoux M., Rabkin S. W., Young T. K., Sweet L. E. Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ. 1992 Jun 1;146(11):2009–2019. [PMC free article] [PubMed] [Google Scholar]
  17. Reisin E., Abel R., Modan M., Silverberg D. S., Eliahou H. E., Modan B. Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med. 1978 Jan 5;298(1):1–6. doi: 10.1056/NEJM197801052980101. [DOI] [PubMed] [Google Scholar]
  18. Stamler R., Stamler J., Riedlinger W. F., Algera G., Roberts R. H. Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA. 1978 Oct 6;240(15):1607–1610. doi: 10.1001/jama.240.15.1607. [DOI] [PubMed] [Google Scholar]
  19. Stevens V. J., Corrigan S. A., Obarzanek E., Bernauer E., Cook N. R., Hebert P., Mattfeldt-Beman M., Oberman A., Sugars C., Dalcin A. T. Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. Arch Intern Med. 1993 Apr 12;153(7):849–858. [PubMed] [Google Scholar]
  20. Wassertheil-Smoller S., Blaufox M. D., Oberman A. S., Langford H. G., Davis B. R., Wylie-Rosett J. The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. Arch Intern Med. 1992 Jan;152(1):131–136. [PubMed] [Google Scholar]
  21. Whelton P. K., Appel L. J., Espeland M. A., Applegate W. B., Ettinger W. H., Jr, Kostis J. B., Kumanyika S., Lacy C. R., Johnson K. C., Folmar S. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group. JAMA. 1998 Mar 18;279(11):839–846. doi: 10.1001/jama.279.11.839. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES